TY  - JOUR
AU  - Kudo, Masatoshi
PY  - 2023
TI  - Adjuvant atezolizumab-bevacizumab after curative therapy for hepatocellular carcinoma
JF  - Hepatobiliary Surgery and Nutrition; Vol 12, No 3 (June 01, 2023): Hepatobiliary Surgery and Nutrition
Y2  - 2023
KW  - 
N2  - 
UR  - https://hbsn.amegroups.org/article/view/113937